# Liquid Phase Concentrated Growth Factor Versus Conventional Arthrocentesis in Temporomandibular Disc Displacement

> **NCT07075276** · NA · RECRUITING · sponsor: **Horus University** · enrollment: 32 (estimated)

## Conditions studied

- Temporomandibular Disorders (TMD)
- Internal Derangement of the Tempromandibular Joint
- Anterior Disc Displacement

## Interventions

- **PROCEDURE:** Liquid Phase Concentrated Growth Factor
- **PROCEDURE:** Conventional arthrocentesis

## Key facts

- **NCT ID:** NCT07075276
- **Lead sponsor:** Horus University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2026-05-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07075276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07075276, "Liquid Phase Concentrated Growth Factor Versus Conventional Arthrocentesis in Temporomandibular Disc Displacement". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07075276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*